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REVIEWARTICLE
Perturbed autophagy and DNA repair converge
to promote neurodegeneration in amyotrophic
lateral sclerosis and dementia
Callum Walker1,2 and Sherif F. El-Khamisy1,3
Maintaining genomic stability constitutes a major challenge facing cells. DNA breaks can arise from direct oxidative damage to the
DNA backbone, the inappropriate activities of endogenous enzymes such as DNA topoisomerases, or due to transcriptionally-
derived RNA/DNA hybrids (R-loops). The progressive accumulation of DNA breaks has been linked to several neurological
disorders. Recently, however, several independent studies have implicated nuclear and mitochondrial genomic instability, perturbed
co-transcriptional processing, and impaired cellular clearance pathways as causal and intertwined mechanisms underpinning
neurodegeneration. Here, we discuss this emerging paradigm in the context of amyotrophic lateral sclerosis and frontotemporal
dementia, and outline how this knowledge paves the way to novel therapeutic interventions.
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Genomic instability: a
neuronal perspective
The ability to maintain genomic integrity represents a
major challenge facing cells. A variety of exogenous and
endogenous agents can induce DNA damage (Ciccia and
Elledge, 2010) with each cell estimated to process 1013
lesions each day (Lindahl and Barnes, 2000). Many normal
cellular processes induce DNA damage. For example, react-
ive oxygen species, a natural by-product of cellular respir-
ation, oxidize nucleic acids causing DNA damage (Valko
et al., 2006). The faulty action of DNA processing en-
zymes, such as DNA ligases and topoisomerases, induce
DNA lesions (El-Khamisy et al., 2005; Ahel et al., 2006).
Furthermore, the fundamental cellular process of transcrip-
tion leads to additional DNA damage due to the formation
of DNA/RNA hybrids (R-loops) (Skourti-Stathaki and
Proudfoot, 2014). The cell is therefore under constant pres-
sure to maintain genomic stability.
The DNA damage response comprises multiple distinct
repair pathways, each taking precedence in response to dif-
ferent forms of damage (Ciccia and Elledge, 2010). More
often, damage to the DNA duplex is restricted to one
strand of the phosphodiester backbone (single-stranded
breaks), but can also occur on both strands (double-
stranded breaks, DSBs). Though less common, DSBs are
highly mutagenic and cytotoxic (Khanna and Jackson,
2001). To address this threat, cells have evolved a high
ﬁdelity DSB repair mechanism, homologous recombination,
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which utilizes sister chromatids as a template for polymer-
ase rectiﬁcation (Hartlerode and Scully, 2009). During G2
and S phase, cells can utilize homologous recombination to
perform error-free DSB repair. Post-mitotic neurons, how-
ever, are intrinsically homologous recombination-deﬁcient
(El-Khamisy, 2011; Rulten and Caldecott, 2013), relying
on error-prone non-homologous end-joining to repair
DSBs.
DNA repair defects often present themselves clinically as
neurological disease (Madabhushi, et al., 2014). For ex-
ample, DSB repair dysfunction leads to the neurodegenera-
tive diseases, ataxia telangiectasia (Savitsky et al., 1995)
and ataxia telangiectasia-like disorder (Stewart et al.,
1999). Single-stranded break repair defects are also asso-
ciated with a number of neurological diseases, including
cerebellar ataxias (Moreira et al., 2001, 2004; Takashima
et al., 2002; Hoch et al., 2017), and has been implicated in
Cockayne syndrome (Nance and Berry, 1992) and xero-
derma pigmentosum (Kraemer, et al., 1987). More recently,
defective DNA repair has been characterized as an import-
ant pathological process in motor neuron disease, otherwise
known as amyotrophic lateral sclerosis (ALS).
Amyotrophic lateral sclerosis
ALS is a heterogeneous disease characterized by the loss of
motor neurons. While sporadic in 90% of patients, 10%
are familial and are caused by mutations in myriad of
genes. ALS-causing mutations often occur within genes
associated with RNA processing or cellular degradation
(Hardiman et al., 2017). Interestingly, ALS patients can
develop frontotemporal dementia (FTD) in unison and the
two diseases appear to co-exist in a single disease spectrum
(Couratier et al., 2017). Mutations in the TARDBP gene,
encoding the RNA processing factor TAR DNA-binding
protein-43 (TDP-43), are known to cause ALS and FTD
(Kabashi et al., 2008). In addition, mutations in other
RNA processing factors, such as FUS (encoding fused in
sarcoma) (Kwiatkowski et al., 2009; Vance et al., 2009),
SETX (encoding senataxin) (Chen et al., 2004), and
HNRNPA/B (encoding heterogeneous nuclear ribonucleo-
protein A/B, hnRNPAB) (Kim et al., 2013) also cause
ALS. Mutations in the SMN1 gene (encoding the core spli-
ceosome component survival of motor neuron, SMN), lead
to a severe form of juvenile motor neuron disease called
spinal muscular atrophy (Melki et al., 1990). Thus, motor
neuron disease is frequently associated with mutations in
genes involved with RNA processing.
As well as RNA processing dysfunction, ALS is strongly
associated with defects in autophagy and the ubiquitin pro-
teasome system (UPS) (Majcher et al., 2015; Hardiman
et al., 2017), which are the primary degradation pathways
available to mammalian cells. Mutations in VCP (encoding
valosin-containing protein, also known as p97 or Cdc48),
cause ALS, FTD and a related syndrome known as inclu-
sion body myopathy with Paget disease of bone and
frontotemporal dementia (IBMPFD) (Watts et al., 2004;
Johnson et al., 2010). VCP functions as a central compo-
nent of the UPS (Meyer and Weihl, 2014), and is also
implicated in autophagy (Majcher et al., 2015). Alike
VCP, mutations in the SQSTM1 gene (encoding p62, also
known as sequestosome-1) cause ALS, FTD and IBMPFD
(Fecto et al., 2011; Rea et al., 2014). P62 is important for
the process of ubiquitin-mediated autophagy (Pankiv et al.,
2007; Katsuragi et al., 2015), and ALS-causing mutations
perturb this process (Goode et al., 2016). Mutations in the
UBQLN2 gene (encoding for ubiquillin-2), which acts as a
dual regulator of autophagy and the ubiquitin proteasome
system (Ceballos-Diaz et al., 2015; Osaka et al., 2016), also
cause ALS (Deng et al., 2011). Taken together, these ex-
amples demonstrate that genetic perturbations in cellular
clearance pathways are also associated with ALS.
A hexanucleotide repeat expansion contained within the
ﬁrst intron of the C9orf72 gene, was recently discovered to
be the most common genetic cause of ALS and FTD
(DeJesus-Hernandez et al., 2011; Renton et al., 2011).
The C9orf72 protein is now characterized as an autophagy
coactivator (Webster et al., 2016; Yang et al., 2016).
C9orf72 protein levels are also reduced in patient tissue
(DeJesus-Hernandez et al., 2011; Belzil et al., 2013;
Waite et al., 2014), suggesting a possible role for haploin-
sufﬁciency and defective autophagy in C9orf72-ALS. In
addition, RNA molecules transcribed from the C9orf72 ex-
pansion form nuclear RNA foci (Zu et al., 2013; Cooper-
Knock et al., 2014). Intronic C9orf72 RNAs are also ex-
ported into the cytoplasm, and undergo repeat associated
non-ATG dependent (RAN)-translation (Ash et al., 2013;
Zu et al., 2013), producing ﬁve dipeptide repeat proteins.
C9orf72 expansions are associated with aberrant nucleocy-
toplasmic transport (Freibaum et al., 2015; Jovicic et al.,
2015; Zhang et al., 2015a), dysfunctional RNA processing
(Lee et al., 2013; Cooper-Knock et al., 2014; Prudencio
et al., 2015; Yin et al., 2017), and impaired cellular clear-
ance mechanisms (Zhang et al., 2014; Gao et al., 2017;
Gupta et al., 2017; Ramesh and Pandey, 2017). It is
thought that some contribution of these factors conspires
to drive neurodegeneration in C9orf72-ALS.
In line with the genetic aetiology of ALS, CNS tissues
from around 97% of ALS patients, including both sporadic
and familial cases, display the mislocalization and aggrega-
tion of TDP-43 (TDP-43 proteinopathy) (Neumann et al.,
2006; Ling et al., 2013). Given the role of TDP-43 in nu-
clear RNA processing pathways (Scotter et al., 2015), TDP-
43 mislocalization likely represents a loss of its nuclear
function and a defect in RNA processing. Sporadic and
familial ALS patient tissues also display a second disease
hallmark, the accumulation and aggregation of p62. P62
binds to misfolded protein aggregates, targeting them for
degradation by autophagy (Bjørkøy et al., 2005). P62 itself
is degraded during autophagy (Ichimura et al., 2008) and
the accumulation of p62 in ALS patients likely indicates a
defect in this process. Understanding the pathological
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consequences of these two disease hallmarks will likely
unlock the door to novel treatment options for ALS
patients.
ALS-linked RNA processing factors
are guardians of the genome
In the past decade, it has become apparent that transcrip-
tion is a primary source of DNA damage, and that RNA
processing factors are important guardians of the genome
(Dutertre et al., 2016). RNA/DNA hybrids form during
transcription when the nascent RNA transcript anneals to
the template DNA strand, displacing the complementary
DNA strand, and yielding a three-stranded nucleic structure
known as an R-loop (Aguilera and Garcia-Muse, 2012). R-
loop accumulation leads to genomic instability (Huertas
and Aguilera, 2003; Li et al., 2005; Tuduri et al., 2009;
Sollier et al., 2014), and thereby couples RNA processing
to the regulation of genomic stability. This was ﬁrst
observed when yeast mutant strains lacking members of
the THO complex (mammalian equivalent of the transcrip-
tion and export, TREX, complex) displayed increased num-
bers of R-loops and DNA breaks (Huertas and Aguilera,
2003). Similar results were observed after serine/arginine-
rich splicing factor 1 (SRSF1) depletion in vertebrates (Li
et al., 2005), demonstrating that RNA processing factors
Figure 1 ALS-linked RNA processing factors are guardians of the genome. (A) Several factors associated with RNA processing,
including FUS and TDP-43, are required to maintain R-loop homeostasis. Their depletion leads to R-loop-mediated genomic instability. (B) The
resolution of R-loops involves the recruitment of the RNA/DNA helicase, SETX, which is recruited to R-loops by SMN - defects in either cause
motor neuron cell death.
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are important regulators of R-loop homeostasis.
Mechanistically, it is speculated that RNA processing fac-
tors prevent R-loop formation in a preventative fashion
(Fig. 1A), by binding to the nascent RNA transcript and
blocking R-loop formation (Chan et al., 2014b). In follow-
up studies, a separate class of transcription and export pro-
teins, known as hnRNPs, were linked to the regulation of
R-loops (Santos-Pereira et al., 2013). HNRNP mutations
cause ALS and FTD (Kim et al., 2013), but whether these
mutations induce R-loop-mediated genomic instability has
not yet been reported.
A similar phenomenon has since been observed for the
ALS-linked RNA processing factors, FUS and TDP-43 (Hill
et al., 2016). Depletion of either leads to an increase in
DSBs, which are reduced by overexpression of the
R-loop-speciﬁc nuclease, RNase H1. TDP-43 and FUS
form damage-induced nuclear foci, which co-localize with
RNA polymerase 2 and phosphorylated histone H2AX
(H2AX) (Hill et al., 2016). These data suggest that
TDP-43 and FUS function at the interface between tran-
scription and DNA repair, likely by controlling R-loop
levels. Based on this work, another interesting hypothesis
is that TDP-43 proteinopathy may function similar to TDP-
43 depletion, and induce R-loop-associated genomic in-
stability. This would be of signiﬁcance as 97% of ALS
cases display TDP-43 proteinopathy (Neumann et al.,
2006; Ling et al., 2013). Other ALS-mutant RNA process-
ing factors exhibit similar cytoplasmic mislocalization
(Kapeli et al., 2017), suggesting that the nuclear-cytoplas-
mic shuttling of RNA binding proteins is an important dis-
ease mechanism. Indeed, defects in nucleocytoplasmic
transport have emerged as an important pathological mech-
anism in C9orf72-ALS (Freibaum et al., 2015; Jovicic et al.,
2015; Zhang et al., 2015a). As well as the cytoplasmic
accumulation of RNA processing proteins, the nuclear ac-
cumulation of mRNA has also been observed in C9orf72-
ALS disease models (Rossi et al., 2015), suggesting that
improper RNA export is a consequence of dysfunctional
RNA processing. An interesting avenue for future research
would be to assess the association between nucleocytoplas-
mic transport defects, dysfunctional RNA processing, and
the levels of R-loop-associated genomic instability.
In addition to R-loop protection via RNA processing fac-
tors, R-loops can be resolved by RNase H1, which de-
grades the RNA strand of RNA/DNA hybrids (Cerritelli
and Crouch, 2009). A number of RNA/DNA helicases
have also been implicated in the resolution of R-loops
(Skourti-Stathaki et al., 2011; Yuce and West, 2013;
Hodroj et al., 2017; Song et al., 2017). For instance, the
RNA/DNA helicase, SETX, has been linked to the reso-
lution of R-loops (Skourti-Stathaki et al., 2011; Yuce and
West, 2013). Notably, autosomal dominant mutations in
the SETX gene are known to cause a juvenile form of
ALS, referred to as ALS4 (Chen et al., 2004). In addition,
autosomal recessive mutations in SETX can cause ataxia
with oculomotor apraxia 2 (AOA2) (Moreira et al.,
2004). Disease mutations appear to occur within the
helicase domain or within its N-terminal protein–protein
interaction domain, suggesting either loss of helicase activ-
ity or loss of functional interactions is pathological.
Nonsense mutations in the SMN1 gene lead to a juvenile
form of motor neuron disease called spinal muscular atro-
phy (SMA) (Melki et al., 1990). Recent evidence suggests
that SMN is also important for the resolution of R-loops
(Zhao et al., 2016). Mechanistically, the tudor domain of
SMN was shown to be a requisite for the recruitment of
SETX to R-loops, and spinal muscular atrophy patient
ﬁbroblasts display increased levels of R-loops and DSBs
(Zhao et al., 2016). In addition, a mouse model of spinal
muscular atrophy recapitulated these two hallmarks of gen-
omic instability (Jangi et al., 2017), suggesting that SMN is
an important factor in the prevention of R-loop-driven gen-
omic instability. These reports suggest that motor neuron
cells may be particularly sensitive to perturbations in R-
loop homeostasis, caused by defects in RNA binding pro-
teins (Fig. 1B).
R-loops are enriched at GC-rich sites of the genome
(Chan et al., 2014a), which may occur because guanine-
rich RNA: cytosine-rich DNA duplexes are thermodynam-
ically more stable than the respective DNA: DNA duplex
(Roy and Lieber, 2009). Susceptibility to R-loops is also
increased by the presence of G-quadruplex structures
(Duquette et al., 2004; Aguilera and Garcia-Muse, 2012),
which assemble in G-rich DNA sequences. The C9orf72
repeat expansion has a high GC content and is known to
form G-quadruplex structures (Haeusler et al., 2014; Zhou
et al., 2015; Brcic and Plavec, 2017). Unsurprisingly, R-
loops have been identiﬁed in vitro following the transcrip-
tion of C9orf72 expansions (Haeusler et al., 2014).
C9orf72 RNA also forms G-quadruplex structures, which
sequester a number of RNA binding proteins (Cooper-
Knock et al., 2014). The sequestration of certain RNA
processing factors may impede their function in R-loop pre-
vention. In-line with this idea, cells expressing C9orf72 ex-
pansion constructs, as well as C9orf72-ALS post-mortem
tissues, display increased R-loop levels (Walker et al.,
2017). The accumulation of R-loops in C9orf72 expansion
expressing cells is a source of genomic instability, since
overexpression of SETX reduces levels of DSBs. SETX
overexpression also reduced cellular toxicity in C9orf72
expansion-expressing cells (Walker et al., 2017), indicating
that excessive R-loop accumulation is able to promote cell
death in cellular models of ALS. Taken together, recent
evidence suggests that RNA misprocessing, in the context
of ALS, results in R-loop accumulation and the formation
of toxic DSBs.
Double-strand break repair signalling
Following DSB induction, the MRN (Mre11, Rad50, Nbs1)
complex form foci at the break site (Williams et al., 2007),
which promotes ataxia-telangiectasia mutated (ATM)
autophosphorylation at serine 1981 (Uziel et al., 2003).
ATM then sets into motion the DNA damage response:
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histone H2AX is phosphorylated on serine 139 by ATM,
ATR and DNA-PK (Rogakou et al., 1998; Blackford and
Jackson, 2017). Phosphorylated H2AX recruits the medi-
ator of DNA damage checkpoint 1 (MDC1) (Hartlerode
and Scully, 2009), inducing the recruitment of the E3 ubi-
quitin ligase, RNF8 (Kolas et al., 2007), which associates
with phosphorylated TQ sites of MDC1 and attaches
mono-K63-linked ubiquitin chains to H2A(X) (Huen
et al., 2007; Kolas et al., 2007; Mailand et al., 2007).
RNF168 associates with these mono-ubiquitylated chains,
and further catalyses the mono- and poly-ubiquitylation of
H2A(X) (Stewart et al., 2009). The ubiquitylation of
H2A(X) by RNF168 is mandatory for the recruitment of
53BP1 and BRCA1 to sites of DSBs (Wang and Elledge,
2007), whose recruitment dictates DSB repair choice
towards non-homologous end-joining or homologous re-
combination, respectively (Ciccia and Elledge, 2010).
Interestingly, 53BP1 recruitment to sites of DSBs is also
required for concentrating ATM into nuclear foci at DSBs
(Noon et al., 2010), suggesting a reciprocal relationship
between ATM and 53BP1 in mediating DSB repair.
Defective autophagy leads to
defective DNA repair signalling
P62 plays a central role in selective autophagy and the UPS
(Katsuragi et al., 2015), which require its LC3-binding
(LCB) and ubiquitin-associated (UBA) domains. While
p62 resides predominantly in the cytoplasm, it is also
found in the nucleus (Wang et al., 2016). P62 binds to
misfolded protein aggregates and targets them for degrad-
ation (Bjørkøy et al., 2005). During p62-mediated autop-
hagy, p62 is degraded along with its substrate, therefore
autophagy self-regulates the cellular levels of p62
(Ichimura et al., 2008). In turn, the accumulation of protein
aggregates or defects in autophagy leads to p62 accumula-
tion (Korolchuk et al., 2009; Wang et al., 2016). Recently,
a seminal discovery demonstrated that excessive p62 acts as
a negative regulator of DSB repair signalling (Wang et al.,
2016). Initially, it was observed that p62 depletion leads to
increased levels of nuclear ubiquitylated protein foci, while
p62 overexpression induced the opposing effect and
similarly decreased levels of H2A ubiquitylation.
Overexpression of p62 also prevented damage-induced
53BP1 foci formation, which could also be recapitulated
by treating wild-type cells with the autophagy inhibitor,
3-methyladenine (3-MA). Importantly, 3-MA did not
induce DSB repair defects in p62 depleted cells, demon-
strating that autophagy inhibition leads to DSB repair im-
pairment in a p62-dependant manner.
Biochemical assays demonstrated that p62-mediated DSB
repair inhibition was a consequence of RNF168 sequestra-
tion, an E3 ubiquitin ligase that functions to recruit 53BP1
to DNA breaks (Stewart, 2009). P62 binds to the MIU
(motif interacting with ubiquitin) domain of RNF168,
which is important for its E3 ligase activity (Wang et al.,
2016). On the other hand, the LIM-binding (LB) domain of
p62 (residues 170–220) mediates RNF168 sequestration
and DSB repair inhibition. These data demonstrate that
the accumulation of p62 impairs the DNA damage re-
sponse. Interestingly, ALS-causing p62 mutations can
occur in or around the LC3 domain of p62 (Fig. 2A),
causing autophagy defects and the accumulation of
mutant p62 (Rubino et al., 2012; Goode et al., 2016).
An interesting future experiment would be to determine
whether ALS-causing mutations in p62 cause DSB repair
defects.
C9orf72 repeat expansions lead to
genomic instability
Excitingly to the ﬁeld of ALS, p62 accumulation is a hall-
mark feature of patient CNS tissues (Blokhuis et al., 2013),
including C9orf72-ALS (Troakes et al., 2012), suggesting
that this hallmark pathology may be associated with defects
in DNA repair. Recently, it was demonstrated that C9orf72
repeat expansions cause defective DNA repair, as indicated
by decreased H2A ubiquitylation, impaired 53BP1 and
phosphorylated ATM (pATM) repair foci, and increased
levels of DSBs (Walker et al., 2017). RNF168-mediated
H2A ubiquitination is important for regulating 53BP1
and ATM mediated repair (Noon et al., 2010). In turn,
RNF168 overexpression or p62 depletion restored DSB
repair and reduced levels of DSBs in C9orf72 expansion
expressing cells (Fig. 2B). These data demonstrate that de-
fective autophagy, indicated by p62 accumulation, is a
driver of genome instability in C9orf72-ALS disease
models (Walker et al., 2017). It is likely that this phenom-
enon also occurs in non-C9orf72 ALS subtypes that exhibit
p62 accumulation.
Increased DNA damage response activation in C9orf72-
ALS patients has been corroborated by two separate re-
ports (Farg et al., 2017; Walker et al., 2017), which
demonstrated that motor neurons from C9orf72-ALS pa-
tients display increased levels of WH2AX phosphorylation.
It was demonstrated by immunohistochemistry that phos-
phorylated levels of ATM were increased in C9orf72-ALS
motor neurons (Farg et al., 2017), though the authors did
not observe or quantify pATM repair foci. Importantly,
defective ATM signalling in C9orf72-ALS was found to
be the result of RNF168 dysfunction, a process that pro-
motes the focal concentration of ATM but not its overall
activation (Noon et al., 2010). Using western blotting from
unfractionated spinal cord homogenates, it was reported
that C9orf72-ALS patient tissues have increased levels of
53BP1 protein (Farg et al., 2017). Importantly, the extrac-
tion protocol used by the authors does not appear to ex-
tract the chromatin-bound fraction of tissue lysates, where
53BP1 protein engaged in DNA repair is enriched. Thus,
neither pATM immunohistochemistry nor 53BP1 western
blotting are indicative of DNA repair capacity. A crucial
future experiment is to assess levels of 53BP1 repair foci in
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C9orf72-ALS tissues, particularly in those cells that are en-
riched with the hallmark accumulation of p62, and to
repeat the immunoblotting experiments to speciﬁcally
examine the levels of chromatin-bound 53BP1.
In other research, the expression of C9orf72-related poly-
glycine-arginine dipeptide repeats (poly-GR DPRs) was
shown to cause increased levels of genomic instability
(Lopez-Gonzalez et al., 2016). Unlike previous work,
poly-GA DPRs did not induce H2AX foci formation,
though they were not quantiﬁed. A similar increase in
DSBs was observed in C9orf72-ALS induced pluripotent
stem cell-derived motor neurons, when compared to non-
ALS controls (Lopez-Gonzalez et al., 2016). Treatment
with antioxidants partially decreased levels of nuclear
DNA damage, suggesting that elevated levels of reactive
oxygen species (or defective repair of reactive oxygen spe-
cies-induced lesions) contributes to genome instability in
C9orf72-ALS. In summary, there is now a wealth of evi-
dence showing that C9orf72 expansions cause genomic in-
stability. This is likely driven by multiple sources: (i) RNA
processing dysfunction and R-loops accumulation; (ii) de-
fects in autophagy and p62-mediated inhibition of DNA
repair; and (iii) mitochondrial perturbations and the gener-
ation of reactive oxygen species.
Familial ALS proteins are
double-strand break repair players
ALS-linked genomic instability can therefore arise, indir-
ectly, due to deﬁcits in RNA processing and/or cellular
clearance pathways. In addition to these mechanisms, pro-
teins commonly mutated in ALS have been shown to play a
more direct role in DSB repair. For example, VCP is a
novel DSB repair player and its depletion leads to elevated
levels of DSBs (Acs et al., 2011; Meerang et al., 2011).
Mechanistically, VCP functions to catalyse the removal of
lysine 48 ubiquitin conjugates at DNA damage sites, which
is obligatory for the recruitment of DNA repair factors. As
in C9orf72-ALS, VCP depletion impairs the recruitment of
Figure 2 Defective autophagy leads to defective DNA repair signalling. (A) A schematic depicting the structure of p62 highlighting
ALS, FTD, and IBMPFD missense mutations. (B) Autophagy maintains functional DNA repair by preventing p62 accumulation. In the context of
ALS, where p62 accumulates, RNF168-mediated H2A ubiquitylation (U) is perturbed, leading to impaired DSB repair and genomic instability.
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the DNA repair factor, 53BP1, to sites of DNA damage
(Acs et al., 2011; Meerang et al., 2011), suggesting a
common theme by which 53BP1-mediated DNA repair is
defective in ALS (Fig. 3A). In the absence of VCP,
L3MBTL1 is constitutively bound to H4K20me2, a histone
residue that is recognized by the tudor domain of 53BP1,
thereby blocking 53BP1 recruitment (Acs et al., 2011). VCP
is therefore required to remove L3MBTL1 and unmask
H4K20me2 residues, permitting 53BP1 recruitment
(Fig. 3B).
VCP has been further implicated in DSB repair, by
removing lysine 48 conjugated Ku70/80 rings from DNA
(van den Boom et al., 2016). Failure to remove Ku70/Ku80
rings perturbs DSB repair, leading to genomic instability.
How ALS causing mutations in VCP affect DSB repair,
however, is not yet clear. Some ALS-causing VCP muta-
tions affect the ATP binding domain of VCP (Fig. 3A)
(Schuetz and Kay, 2016). Since the ATPase activity is
required for its function in regulating DSB repair
(Meerang et al., 2011; van den Boom et al., 2016), it is
likely that these mutations result in an impairment of DNA
repair signalling. Furthermore, due to its additional role in
cellular degradation pathways, VCP mutations cause p62
accumulation in patient samples (Ayaki et al., 2014), and
may therefore cause additional defects in DNA repair
through p62-dependant processes. Taken together, these
data indicate that VCP has a direct role in repairing
DNA breaks.
In addition to VCP, the ALS-linked protein FUS has also
been implicated in repairing DNA breaks (Fig. 4A) (Wang
et al., 2013; Rulten et al., 2014). FUS depletion leads to
impaired 53BP1 foci and increased DNA damage (Wang
et al., 2013), bearing striking similarities to what has
been observed following the expression of C9orf72 expan-
sions and the depletion of VCP (Acs et al., 2011; Meerang
et al., 2011; Walker et al., 2017). FUS recruitment to DSBs
is facilitated by interactions with HDAC1, and ALS-linked
FUS mutations impede this interaction and perturb DSB
Figure 3 The familial ALS protein VCP promotes DNA repair. (A) A schematic depicting the structure of VCP protein highlighting ALS,
FTD, and IBMPFD missense mutations. (B) VCP functions to catalyse the removal of ubiquitylated proteins from chromatin, including L3MBTL1.
The removal of L3MBTL1 from methylated (M) histone H2A(X) permits 53BP1 recruitment to DSBs, enabling DNA repair by non-homologous
end-joining. Loss of VCP leads to impaired removal of L3MBTL1, leading to impaired non-homologous end-joining and genomic instability.
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repair (Fig. 4A and B) (Wang et al., 2013). Finally, FUS-
ALS patient tissues display increased DNA damage, as
measured by WH2AX levels in neuronal cells. In a separate
study, FUS recruitment to DNA damage was dependent on
PARP-1 catalytic activity (Rulten et al., 2014). It was also
shown that FUS binds directly to PAR chains and that
ALS-causing mutations decrease this interaction (Rulten
et al., 2014). Taken together, these data indicate that
FUS is a member of the DNA damage response, and indi-
cate that ALS-associated defects in FUS lead to defects in
DNA repair processes.
More recently, it was shown that mutation variants of
the NIMA-related kinase 1 (NEK1) gene confer susceptibil-
ity to ALS (Kenna et al., 2016). NEK1 has been implicated
in the repair of DSBs by homologous recombination (Spies
et al., 2016), functioning to phosphorylate Rad54 and
ensuring the adequate removal of chromatin-associated
Rad51 ﬁlaments, which is required for homologous recom-
bination completion. Mutations in C21orf2, an interactor
of NEK1, are also associated with ALS (van Rheenen et al.,
2016). Moreover, its depletion similarly leads to defects in
homologous recombination (Fang et al., 2015). Many ca-
nonical homologous recombination factors, such as BRCA1
and BRCA2, have been linked to the processing of R-loops
(Bhatia et al., 2014; Hatchi et al., 2015; Tan et al., 2017;
Zhang et al., 2017). We therefore would like to propose
that NEK1 and C21orf2 play a role in controlling R-loop
homeostasis, which may explain at least in part their asso-
ciation with ALS.
Heterochromatin: protecting
from R-loops but perturbing
DNA repair
Eukaryotic DNA is highly organized, typically the cell
houses active genes in open euchromatic DNA, while
Figure 4 The familial ALS protein FUS promotes DNA repair. (A) A schematic depicting the structure of the FUS protein with ALS
missense mutations highlighted. (B) FUS functions to regulate the DNA damage response through interactions with HDAC1 and PARP1. These
interactions are important for H2AX phosphorylation (P) and 53BP1-mediated DSB repair. Loss of FUS or ALS-linked mutations leads to defective
DSB repair and genomic instability.
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non-transcribed or repressed genetic material is housed in
tightly bound heterochromatin. In addition to promoting
genomic instability, R-loops have been shown to alter the
chromatin landscape by increasing levels of heterochro-
matic DNA. Of note, R-loop accumulation increases the
levels of H3S10P (Castellano-Pozo et al., 2013), a hetero-
chromatic histone mark usually associated with mitosis.
More recently, the same group demonstrated that R-loop-
driven H3S10P formation is a requisite for subsequent gen-
omic instability (Garcia-Pichardo et al., 2017). Whether
levels of H3S10P are therefore perturbed in in ALS samples
is yet to be tested.
It was also demonstrated that H3K9 methylation is en-
riched in response to R-loop accumulation (Castellano-
Pozo et al., 2013). Increased H3K9 methylation has been
reported in C9orf72-ALS (Belzil et al., 2013; Walker et al.,
2017), which might be driven by the aberrant accumulation
of R-loops in ALS (Haeusler et al., 2014; Walker et al.,
2017). Interestingly, this mark has also been associated
with Friedreich’s ataxia and fragile X syndrome, whereby
trinucleotide repeat expansions were shown to cause R-
loop-dependent H3K9me2 deposition (Groh et al., 2014).
H3K9 methylation marks and R-loops are also enriched at
GC-rich transcriptional pause sites (Skourti-Stathaki et al.,
2014). It is postulated that H3K9 methylation may play a
protective role, since abolishment of all H3K9 methylation
induces massive R-loop accumulation and genomic instabil-
ity in Caenorhabditis elegans (Zeller et al., 2016). These
data couple R-loop accumulation to the presence of hetero-
chromatic DNA. An attractive model for this association is
that the formation of repressive heterochromatin serves to
reduce transcriptional activity and protect from dangerous
R-loop-mediated instability.
While heterochromatin may protect the cell from the
toxic effects of R-loops, the accumulation of heterochroma-
tin represents an obstacle for DNA repair. Work in the
Jeggo laboratory demonstrated that heterochromatic DSBs
display slower repair kinetics than euchromatic breaks
(Goodarzi et al., 2008; Noon et al., 2010). Interestingly,
ATM and 53BP1 are particularly required for the repair of
heterochromatic DSBs (Dimitrova et al., 2008) and the in-
hibition of either impairs the resolution of heterochromatic
DNA breaks (Goodarzi et al., 2008; Noon et al., 2010).
Mechanistically, ATM-mediated phosphorylation of
KRAB-associated protein 1 (KAP1), a bona fide heterochro-
matic protein, was shown to release KAP1 from hetero-
chromatin and enable DSB repair (Goodarzi et al., 2008).
53BP1 was subsequently shown to be upstream of ATM-
mediated phosphorylation of KAP1 (Noon et al., 2010),
acting to concentrate active ATM at sites of DSBs. It is
conceptualized that the phosphorylation and mobility of
KAP1 promotes local chromatin decondensation that en-
ables DNA repair factor access to the break site. In line
with this, the genetic inhibition of KAP1 improves hetero-
chromatic DSB repair kinetics in ATM inhibited cells
(Goodarzi et al., 2008). As such, heterochromatic DSBs
are particularly challenging to cells because they require
additional chromatin remodelling prior to repair.
Paradoxically, recent evidence suggests that the presence
of local heterochromatic DNA is also a requirement for
DSB repair signalling (Sun et al., 2009; Kaidi and
Jackson, 2013; Burgess et al., 2014). The heterochromatic
histone mark, H3K9me3, is required for the damage-de-
pendent activation of the acetyltransferase KAT5 (Sun
et al., 2009). KAT5 activation, in turn, is required for the
activation of ATM (Kaidi and Jackson, 2013). More re-
cently, it was shown that chromatin compaction activates
the DNA damage response, speciﬁcally proteins that occur
upstream in DSB repair signalling, such as H2AX (Burgess
et al., 2014). Importantly, excessive chromatin compaction
impaired the completion of DNA repair and caused
reduced cellular viability (Burgess et al., 2014). These
data suggest that, while heterochromatin is an important
aspect of initial DSB repair signalling, it is ultimately a
barrier to the proper completion of DNA repair.
As such, the careful organization of DNA into euchroma-
tin and heterochromatin is critical to cellular health.
Evidently, perturbations in these processes have been
linked to human disease, such as premature ageing
(Zhang et al., 2015b) and ataxia telangiectasia (Li et al.,
2012, 2013). Chromatin relaxation, via HDAC inhibition
or enhancer of zest homologue 2 (EZH2) depletion, was
able to reduce the cellular and neurological phenotype of
ataxia telangiectasia mouse models (Li et al., 2012, 2013),
suggesting a pathological role for excessive heterochroma-
tin in the neurological aspect of the disease. Elevated levels
of the heterochromatin have also been reported in C9orf72-
ALS samples (Belzil et al., 2013; Walker et al., 2017).
Interestingly, HDAC inhibition was able to reduce DSBs
and cellular toxicity in models of C9orf72-ALS (Walker
et al., 2017). These data implicate excessive heterochroma-
tin formation as a pathological feature of ataxia telangi-
ectasia and ALS, highlighting the potential of HDAC
inhibitors as a means to prevent neuronal cell death.
Whether excessive heterochromatin is the cause or conse-
quence of defective ATM, a feature in both disorders, is yet
to be determined. Nevertheless, these data offer a plausible
therapeutic approach and a new insight into the role of
ATM in controlling chromatin compaction.
Defective ATM signalling provides an
unexpected link between
amyotrophic lateral sclerosis
and ataxia telangiectasia
Defective ATM signalling provides a molecular link be-
tween ALS and ataxia telangiectasia. Curiously, a recently
characterized murine model of ataxia telangiectasia displays
motor neuron cell loss (Quek et al., 2017), indicating that
motor neurons may be particularly sensitive to perturb-
ations in ATM signalling. As well as its canonical role in
DSB repair, ATM signalling is important for the repair of
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topoisomerase I (TOP1) cleavage complexes (Das et al.,
2009). In non-replicating cells, TOP1 cleavage complexes
are primarily repaired by TDP1 (El-Khamisy et al., 2005),
and TDP1 mutations cause the neurodegenerative disease
spinocerebellar ataxia with axonal neuropathy (SCAN-1)
(Takashima et al., 2002). ATM phosphorylates TDP1
(Das et al., 2009) to enhance TOP1 cleavage complex reso-
lution. In addition to TDP1 and ATM, a scaffold protein,
XRCC1, further facilitates the repair of TOP1 cleavage
complexes (Das et al., 2009). Recently, XRCC1 mutations
were identiﬁed in a patient with cerebellar ataxia (Hoch
et al., 2017). As well as promoting neurodegeneration in
man, Atm, Tdp1 and Xrcc1 deletion leads to the accumu-
lation of TOP1 cleavage complexes in mice (Katyal et al.,
2007, 2014; Alagoz et al., 2013). Exposure to camptothe-
cin, which speciﬁcally induces TOP1 cleavage complexes,
also leads to neurodegeneration in mice (Katyal et al.,
2014), further highlighting the pathogenic consequences
of TOP1 cleavage complex in neurons.
Interestingly, TOP1 cleavage complexes are also
increased in cells expressing C9orf72 repeat expansions
(Walker et al., 2017). This is in-line with the observation
that C9orf72 expansions impair ATM signalling. Since de-
fective ATM signalling was a consequence of p62 accumu-
lation, p62 accumulation in other ALS subtypes likely
drives the formation of TOP1ccs. Recently, it was shown
that ATM is activated by R-loops, independently from the
formation of DSBs (Tresini et al., 2015). ATM activation
by R-loops enhances the mobility of the spliceosome, ultim-
ately leading to mis-splicing and the retention of introns
within mRNA transcripts (Tresini et al., 2015). The func-
tion of ATM kinase activity in mediating the cellular re-
sponse to R-loops is yet to be elucidated, though it is
tempting to speculate that these data represent yet another
ATM-mediated repair pathway. In line with this idea,
restoring ATM signalling in cells expressing C9orf72 ex-
pansion expressing cells was able to reduce R-loop levels
(Walker et al., 2017). The function of ATM signalling in
the regulation of R-loop homeostasis, in both health and
disease, represents a fruitful avenue for future research.
Why does defective ATM signalling
caused by C9orf72 expansions not
predispose to cancer or
immunodeficiency?
One of the primary features of ataxia telangiectasia is
cancer predisposition, namely lymphomas (Taylor et al,
2004). The ATM deﬁciency in C9orf72-ALS patients, how-
ever, does not appear to predispose to cancer. While ataxia
telangiectasia and C9orf72-ALS share defective ATM sig-
nalling, the nature and origin of this defect are fundamen-
tally different. The ATM defect in C9orf72-ALS originates
from the impaired ability to degrade misfolded protein ag-
gregates, which leads to p62 accumulation and RNF168
inhibition (Walker et al., 2017). RNF168 deﬁciency impairs
53BP1-mediated sustained signalling of ATM, a non-ca-
nonical pathway complementing the canonical ATM acti-
vation cascade initiated by the MRN complex (Noon et al.,
2010). Notably, RNF168 dysfunction causes another
human disease typiﬁed by radiosensitivity, immunodeﬁ-
ciency and learning difﬁculties called RIDDLE syndrome,
which similarly does not appear to be linked to cancer
predisposition (Stewart et al., 2007). In ataxia telangiecta-
sia, oncogenesis is thought to arise as a consequence of
defective DSB repair by homologous recombination and
defective cell-cycle checkpoint activation (Cremona and
Behrens, 2014). RIDDLE cells, however, display normal
levels of homologous recombination and functional ATM-
mediated cell-cycle checkpoint, potentially protecting pa-
tients from cancer (Stewart et al., 2007). Thus, one possible
explanation for the absence of cancer in C9orf72-ALS is
the retention of functional homologous recombination and
ATM-mediated cell cycle checkpoint, akin to RIDDLE.
While this provides a plausible explanation for the absence
of cancer in C9orf72-ALS, it does not explain the apparent
absence of immunodeﬁciency, a hallmark of defective non-
homologous end-joining in RIDDLE cells. In dividing cells,
misfolded protein aggregates are asymmetrically distributed
into daughter cells, leaving one of the daughter cells aggre-
gate-free (Rujano et al., 2006). Therefore, even if p62 ac-
cumulation occurs in ALS lymphocytes, non-homologous
end-joining dysfunction would only persist for a single
cell cycle and thus the toxic effect of protein aggregation
is inherently ‘diluted’ in cycling cells. Indeed, protein aggre-
gates typically impact non-dividing neuronal cells (Ross
and Poirier, 2004; Taylor et al., 2004; Bjørkøy et al.,
2005; Rujano et al., 2006; Stewart et al., 2007; Cremona
and Behrens, 2014). We favour the latter explanation in
which the magnitude of toxic effects caused by protein ag-
gregation is higher in non-cycling compared to cycling cells,
providing an explanation for the apparent absence of
immunodeﬁciency in C9orf72-ALS. The extent of protein
aggregation and the preset threshold at which non-cycling
cells can tolerate may also explain the selective vulnerabil-
ity of speciﬁc neuronal populations to the toxic effects of
protein aggregations.
The vulnerability of neurons to
oxidative DNA damage
Despite representing only 2% of total body mass, one-ﬁfth
of all oxygen is consumed by the brain (Nicholls and Budd,
2000). Because they metabolize a high proportion of
inhaled oxygen, neurons are likely to be highly susceptible
to damage from reactive oxygen species. The primary free
radical that is formed during cellular respiration is O2

(superoxide) (Murphy, 2009), which is dismutated into
hydrogen peroxide (H2O2) by superoxide dismutase 1
(SOD1). SOD1 mutations cause ALS (Rosen et al., 1993)
and result in high levels of oxidative stress (Tsang et al.,
2014). Reactive oxygen species generated by mutant SOD1
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expression induce breaks in the mitochondria and nucleus
of human cells (Tsang et al., 2014; Chiang et al., 2017).
These breaks also require processing by TDP1 (Ben Hassine
and Arcangioli, 2009; Chiang et al., 2017), and mutant
SOD1 expression in a TDP1 knock-out background was
toxic (Chiang et al., 2017). Thus, ALS-causing SOD1 mu-
tations lead to the over-accumulation of reactive oxygen
species, causing oxidative DNA damage requiring TDP1-
mediated repair. Elevated levels of reactive oxygen species
have also been reported in other ALS subtypes, including
C9orf72-, FUS-, TDP-43- and sporadic-ALS disease models
(Smith et al., 2017).
Therapeutic potential of PARP
inhibition and NAD(+ ) replacement
strategies
Several lines of independent evidence have linked ALS to
genomic instability. Perhaps the most important question,
though, is how can we utilize this knowledge to modulate
the disease? Cerebellar ataxias are commonly caused by
mutations in DNA repair proteins (Madabhushi et al.,
2014). It has become apparent that cells defective in
DNA repair processes typically display PARP1 hyperactiva-
tion (Lee et al., 2009; Krenzlin et al., 2012; Fang et al.,
2014; Scheibye-Knudsen et al., 2014; Hoch et al., 2017), as
greater demand becomes bestowed upon PARP1-mediated
repair pathways. In-line with this idea, XRCC1 knock-out
mouse models display PARP1 hyperactivation (Lee et al.,
2009; Hoch et al., 2017). Deletion of the Parp1 gene in
Xrcc1 knock-out mice is able to prevent neurodegenera-
tion, indicating that the overactivation of PARP1 is a
neurotoxic consequence of defective DNA repair (Hoch
et al., 2017).
PARP enzymes catalyse the addition of poly-ADP-ribose
(PAR) chains onto glutamate or serine residues of target
proteins (Bai, 2015). Cellular pools of NAD+ are the
donor molecule, which PARP enzymes catalyse during
this process. It is postulated that PARP1 hyperactivation
leads to the overconsumption of NAD+ , underpinning
the neurodegeneration observed in XRCC1-null mice
(Hoch et al., 2017). Indeed, several neurological diseases
that are characterized by defective DNA repair, including
ataxia telangiectasia, are associated with PARP1 hyperacti-
vation and low levels of cellular NAD+ (Krenzlin et al.,
2012; Fang et al., 2014, 2016; Scheibye-Knudsen et al.,
2014). These data suggest that pharmacological inhibition
of PARP1 may be protective. However, current PARP1 in-
hibitors have been shown to induce the trapping of PARP1
onto chromatin (Pommier et al., 2016). PARP trapping
would likely cause neurotoxicity by inducing DNA lesions
and blocking transcriptional elongation, making current
PARP inhibitors unsuitable as disease-modifying agents
for treating neurodegeneration. Next generation PARP1 in-
hibitors, which block the enzymatic action of PARP1 while
preventing its trapping onto chromatin, may offer a pro-
mising therapeutic potential for ALS and related diseases.
As well as PARPs, cellular NAD+ is further consumed
by another family of enzymes called sirtuins (SIRTs)
(Vassilopoulos et al., 2011). SIRTs function as NAD+ de-
pendent lysine deacetylases, which regulate a number of
biological processes, including metabolism and DNA
repair (Michan and Sinclair, 2007). SIRT1, for instance,
promotes DSB repair by deacetylating and in turn activat-
ing HDAC1 (Dobbin et al., 2013). SIRT1 activity appears
to be impeded by PARP1 hyperactivation (Canto´ et al.,
2015). In addition, NAD+ replenishment has been shown
to reactivate SIRT1 and prevent neurodegeneration
(Scheibye-Knudsen et al., 2014), thereby compensating for
PARP1 hyperactivation. An attractive model for these data
is that compromised DNA repair leads to PARP1 hyperac-
tivation, resulting in the depletion of NAD+ levels, limiting
NAD+ dependent SIRTs. The repletion of NAD+ there-
fore restores SIRT1 function, reduces genomic instability,
and ultimately prevents neurodegeneration. As such,
NAD+ replenishment strategies represent a promising
new strategy for neurological diseases characterized by
DNA repair dysfunction. Indeed, the repletion of NAD+
has been shown to positively modulate the disease course in
models of ataxia telangiectasia, Cockayne syndrome and
xeroderma pigmentosium (Krenzlin et al., 2012; Fang
et al., 2014, 2016; Scheibye-Knudsen et al., 2014).
Given the emerging role of dysfunctional DNA repair,
particularly defective ATM-mediated repair, in ALS it
may be possible that similar strategies would confer thera-
peutic beneﬁts. Indeed, motor neurons are particularly sen-
sitive to perturbations in cellular NAD+ levels. Deletion of
intracellular nicotinamide phosphoribosyltransferase
(iNAMPT), the rate-limiting enzyme involved in NAD+
biosynthesis, leads to a motor neuron disease phenotype
in mice (Wang et al., 2017). It is striking that the speciﬁc
targeting of NAD+ levels causes a motor neuron disease
phenotype. Moreover, iNAMPT protein levels were signiﬁ-
cantly reduced in ALS patient spinal cord tissues (Wang
et al., 2017), reinforcing the notion that NAD+ replenish-
ment could offer new therapeutic beneﬁt in ALS.
The selective sensitivity of motor
neurons to genomic instability
Motor neurons, like Purkinje cells that degenerate in ataxia
telangiectasia and related disorders, are among the largest
cells of the human body. Their large size is probably linked
to high levels of cellular respiration, elevated levels of tran-
scription and in turn, a high dependency upon functional
cellular clearance pathways to maintain cellular homeosta-
sias. Unsurprisingly, defective RNA processing, impaired
cellular clearance pathways, and dysfunctional mitochon-
drial respiration are linked to the pathogenesis of ALS—
all of which drive genomic instability. Defective RNA pro-
cessing leads to genomic instability due to the formation of
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R-loops, while dysfunctional mitochondrial respiration
leads to oxidative damage. Autophagy defects lead to gen-
omic instability due to the over accumulation of p62 and
the suppression of DSB repair signalling. The high meta-
bolic, transcriptional, and autophagic activity of motor
neurons may render these cells particularly vulnerable to
perturbations in these, intrinsically linked, cellular
processes.
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